Abstract: A therapeutic composition for treating and/or preventing retinal disorder includes intravitreally or transsclerally administered erythropoietin.

Abstract: The present invention provides systems and methods for screening and tracking ophthalmic disease in a plurality of patients. The invention includes a screening subsystem comprising a non-mydriatic camera for obtaining digital images of eyes of the patients, a central database for storing the digital images of the eyes of patients as well as patient demographic data and related health data, and a central server comprising a computer which executes retinopathy grading algorithms, wherein the retinopathy grading algorithms recognize and assign a grade to ophthalmic disease present in the digital eye image and store the results in the central database.

Abstract: A method and apparatus for testing individuals having a sub-optimal central field of vision so as to identify areas within the visual field in which images can be perceived and for determining effects of contrast sensitivity and distortion within such areas such that visual images may be presented, after being enhanced so as to modify the images in accordance with tested parameters, so that the individual will perceive the images in an improved manner.